From Ophthalmic Hyperguides (http://www.ophthalmic.hyperguides.com) Loff HJ & Landa M. Benign eyelid tumors Milder BD. Subjective refraction, Part I Milder BD. Subjective refraction, Part II Milder B. Anisometropia Perry H. Superior limbic keratoconjunctivitis Perry H et al. Conservative treatment of meibomian gland dysfunction Pirnazer JR & McDonnell PJ. LASIK complications Schiff WM, Chang S &Barile GR. Retinal detachment and cataract surgery Schweigerling J. Optics of intraocular lenses Schweigerling J. Lasers Shamie N & McDonnell P. Post-LASIK atypical mycobacterial keratitis Singh AD, Shields CL & Shields JA. Prognostic factors in retinoblastoma Solomon R, Donnenfeld ED & Perry HD. Blepharitis: Diagnosis and management Unwin D. Advanced geometric optics Unwin D. Basic geometric optics Hamaker N & Olitsky SE. Accommodative esotropia Hill WE. The IOL Master Holladay JT. IOL power calculations for the unusual eye Lalchandani G, Levine MR & Bardenstein DS. Orbital rhabdomyosarcoma

References

From Ophthalmic Hyperguides (http://www.ophthalmic.hyperguides.com) Biser SA & Perry HD. Acanthamoeba keratitis Camejo L. Pigment dispersion and pigmentary glaucoma Donaldson KE & Dubovy SR. Sympathetic ophthalmia Donnenfeld ED, & Perry HD. Topical cyclosporine 0.05% in the treatment of dry eye: 2004 Greuloch K. Clinical optical instruments Lane SS. Incorporating aspheric and toric IOLs in your practice: Why and how? Section in the

monograph entitled Improving Treatments with Aspheric Optics in IOL and Laser-Based Vision Correction

Lee AG & Brazis PW. Eye pain for the ophthalmologist

References

From Audio-Digest Ophthalmology Volume 45(6)

Hill WE. Highly accurate IOL power calculations Hill WE. IOL power calculations following keratorefractive surgery

Volume 45(7) Cooney MJ. Wet AMD therapy Boyer D. Treatment of wet AMD: Where are we going?

Volume 45(9). Cionni RJ. Comparison of multifocal IOL technologies Volume 45(14)

Fogel ES. Restasis: It’s not just for dry eye! Weisbrod L. Toxic anterior segment syndrome (TASS)

Volume 45(16). Pickering T. To tube or not to tube? Volume 45(19). Packer M. Refractive cataract surgery; Next-generation IOL technology Volume 45(20). Williams GA. New treatment for neovascular age-related macular degeneration Volume 46(1). Arnold PN. Presbyopia-correcting IOLs Volume 46(3)

Foster CS. Retinal vasculitis: Local or systemic therapy? Duker JS. What’s new in posterior segment tumors?

Volume 46(11). McLeod SD. Pharmacologic management of high-risk corneal grafts Volume 46(20). Foster CS. Scleritis update

References

From Audio-Digest Ophthalmology (cont.) Volume 46(21)

Tang J. Age-related macular degeneration: New trends Ruben JB. Retinopathy of prematurity: Current surveillance guidelines

Volume 46(22). Tomsak RL. Ischemic optic neuropathy update. Volume 48(4). Kieval JZ. Update on endophthalmitis after cataract surgery. Volume 48(6). Coats DK. Retinopathy of prematurity: Debunking common myths Volume 48(8). Foster CS. Uveitis: Current best practices Volume 49(6). Ritch R. Glaucoma and systemic disease Volume 49(9). Duker JS. Update on the management of retinal vein obstruction Volume 49(16). Heier JS. Medical therapy for wet age-related macular degeneration:

Recent pivotal trials and their clinical impact Volume 49(18). Lloyd MJ. An evidenced-based approach to managing glaucoma Volume 49(21)

Olson RJ. Cataract surgery: Gazing into the future Volume 49(23). Monarch PA. Giant cell arteritis Volume 49(24). Lee AG. Five things to tell your next NAION patient (other than “nothing can be

done”) Volume 50(1)

West AL. Nutritional supplements for dry eye disease Finkelstein D. Why we do not search for systemic disease in cases of retinal vein occlusion

Volume 50(8). Burnier MN. Granulomatous uveitis

References

From Audio-Digest Ophthalmology (cont.) Volume 50(19). Foster CS. Immunomodulatory therapy for uveitis Volume 50(22). Mungan NK. Update on retinopathy of prematurity Volume 50(23).Christiansen SP. Conjunctivitis in children Volume 51(7).Serle JB. Glaucoma medications Volume 51(8). Corbett JJ. Optic neuritis and neuromyelitis optica Volume 51(10). Lee AG. Five key diagnoses Volume 51(12). Stamper RL. Visual field testing Volume 51 (24). Shields CL. Tumors in children/uveal melanoma Volume 51(1). Radhakrishnan S. Medical therapy for glaucoma Volume 51(3)

Whelan JP. Uveitis associated with JIA: A rheumatologist’s perspective Foster CS. Uveitis associated with JIA: An ophthalmologist’s perspective

Volume 46(23). Rapuano C. Managing HSV keratitis: The Herpetic Eye Disease Study (HEDS) and beyond

Volume 47(2). Kaufman H. What’s new with Herpes? Volume 47(3). Lee AG. Controversies in neuro-ophthalmology Nov 2018. Lee AG. Five diagnoses outside the scope of comprehensive ophthalmology

References

From UpToDate (www.uptodate.com) Lee A. & Brazis PW. Myopathies affecting the extraocular muscles in children O’Ferrall E. Mitochondrial myopathies: Clinical features and diagnosis Foster S. Ocular cicatricial pemphigoid Hu V et al. Trachoma Wetter DA. Pathogenesis, clinical features, and diagnosis of erythema multiforme High WA & Roujeau J-C. Stevens-Johnson syndrome and toxic epidermal necrolysis:

Pathogenesis, clinical manifestations, and diagnosis Glisson CC. Neuromyelitis optica spectrum disorders Harbour JW & Shih HA. Initial management of uveal and conjunctival melanomas Wesson DE & Lopez ME. Congenital aganglionic megacolon (Hirschsprung disease) Givre S & Garg S. Retinitis pigmentosa: Clinical presentation and diagnosis Shindler KS. Tolosa-Hunt syndrome Frieden IJ & Chu DH. Klippel-Trenaunay syndrome: Clinical manifestations, diagnosis, and

management Galbraith S. Capillary malformations (port wine stains) and associated syndromes Olson TS. Clinical manifestations and diagnosis of Fanconi anemia Niaudet P. Cystinosis Carpenter T. Overview of rickets in children Panush RS et al. Undifferentiated systemic rheumatic (connective tissue) diseases and overlap

syndromes Tolentino M & Petersen E. Toxoplasmosis in immunocompetent hosts

References

References From Wikipedia (http://en.wikipedia.org/wiki/Main_Page)

Ranibizumab Bevacizumab Monoclonal antibodies Nomenclature of monoclonal antibodies Recombinant DNA PEGylation Affinity maturation Anecortave Aptamer Humanized antibody Pegaptanib Small interfering RNA Protein kinase inhibitor Protein kinase Verteporfin Regeneron Toll-like receptors Bacillus cereus Fusion protein Toxoplasma gondii

References From Wikipedia (cont.)

Glaucoma valve Erythrocyte sedimentation rate Homeobox Electroretinography Ishihara color test Myopia Allvar Gullstrand Arthropod Protozoa Helminth Kingdom Fungi Mold Yeast Hypha Optical coherence tomography Fluorescence Autofluorescence Lateral medullary syndrome

References From Wikipedia (cont.)

Parinaud syndrome Anti-neutrophil cytoplasmic antibody Pretectal area Lipofuscin Uhthoff's phenomenon Fabry disease Hereditary nonpolyposis colorectal cancer Thymus Myasthenia gravis Ependymoma Zellweger syndrome Ciliopathy Oculogyric crisis Cavernous sinus ABCA4

References From EyeWiki (http://eyewiki.aao.org/Main_Page)

Goldstein DA. Necrotizing herpetic retinitis Heidar K. Retinopathy of prematurity Herz N. Wavefront testing MJ Spirn. Optical coherence tomography Prall FR. Fluorescein angiography Moss H. Best disease Hung C & Giaconi JA. Glaucomatocyclitic crisis (Posner-Schlossman syndrome) Stenz JM. Peripheral ulcerative keratitis Shah SB. Leber hereditary optic neuropathy Pillai P. Sarcoid uveitis Gomez VMP & Ganatra SR. Marcus-Gunn jaw winking ptosis FitzGibbon EJ. Papilledema Weber AC, Chundury RV & Perry JD. Entropion Khan R et al. Ocular cicatricial pemphigoid Mannis T. Filamentary keratitis Adam GM. Superior limbic keratoconjunctivitis Seibold LK & Solish SP. Normal tension glaucoma Welch RJ & Havens S. Tilted disc syndrome Taney L et al. Acute retinal necrosis Colon-Acevedo B. Acquired oculomotor nerve palsy

References From EyeWiki (cont.)

Mendoza KA & Lauer A. Eales disease Tonk RS. Blepharitis Clamp M. Kearns-Sayre ptosis Kim JM. Nystagmus Monsivais-Rodriguez FV. Preseptal cellulitis Ratchitskaya A. Choroidal osteoma Lee J & Pilhblad MS. Parinaud oculoglandular syndrome Mozayan E & Karth PA. Macroaneurysm Elshatory YM. Age-related macular degeneration Rapoport Y. Neuroblastoma Rajaii F. Basal laminar drusen Wong Lai Man R. Reticular drusen Possin ME & Burkat CN. Rhabdomyosarcoma Hromas A. Stickler syndrome Hura A & Golnik KC. Oculomasticatory myorhythmia Silva NFA. Stargardt disease/fundus flavimaculatus Ajlan R. Cotton wool spots Duff SM & Ramasubramanian. Persistent hyperplastic primary vitreous Kim JE. Hypertensive retinopathy

References From EyeWiki (cont.)

Goldman DR. Angioid streaks Gritz DC. Toxoplasmosis Gil P. Purtscher retinopathy and Purtscher-like retinopathy Koneru S & Karth PA. Photodynamic therapy (PDT)

References From EyeRounds (http://www.eyerounds.org/index.htm )

Bhola R. Intermittent exotropia: A major review Rogers GM, Longmuir SQ. Refractive accommodative esotropia Graff JM. Verticillata: 54-year-old white male with a known history of atrial fibrillation and

hypertension on amiodarone Chen JJ, Tarantola, RM, Kay CN, Mahajan VB. Hydroxychloroquine (Plaquenil) toxicity and

recommendations for screening Carroll JN, Johnson CA. Visual field testing: From one medical student to another Koczman J, Oetting TA: Vernal keratoconjunctivitis: 8-year-old asthmatic male with reduced vision Dahrouj M et al. Posterior polymorphous corneal dystrophy (PPMD) Phillips DL, Folk JC. Behçet's Disease: A 32-year-old female with recurrent ocular inflammation Allen RC. Lateral tarsal strip (video) Allen RC. Transconjunctival retractor reinsertion with lateral tarsal strip for the treatment of

involutional ectropion (video) Clark TJE et al. Involutional entropion: Options for surgical management of entropion Wang JW et al. Ocular manifestations of Stevens-Johnson syndrome Allen RC. Optic nerve sheath fenestration Vislisel J. Iris mammillations Kirkpatrick CA et al. Lattice Corneal Dystrophy Type II – Meretoja's Syndrome

References From EyeRounds (cont)

Vislisel J. Corneal verticillata Saylor MA & Allen RC. Rhabdomyosarcoma Chen JJ et al. Hydroxychloroquine (Plaquenil) Toxicity and Recommendations for Screening

From eMedicine (http://www.medscape.com/) Roque MR, Roque BL, et al. Giant cell arteritis DeAngelis DD, Pang N & Hurwitz J. Lacrimal gland tumors Zee CS, Kim P & Vu V. Pineal germinoma Agranoff AB. Stroke motor impairment Comer GM. Exudative ARMD Arif M. Uveitis, Fuchs heterochromic Farooqui SZ. Uveitis classification Altaweel M et al. CMV retinitis Al-Ghoul AR et al. Toxic anterior segment syndrome Zafar A. Toxic/nutritional optic neuropathy Ellis CR. Wolff-Parkinson-White syndrome Robertson WC. Pediatric idiopathic intracranial hypertension Farid-Moayer M. Churg-Strauss syndrome Parmar MS. Horner syndrome Altaweel M. Best disease Paulino AC. Wilms tumor Singh D. Aniridia Kaye V. Vertebrobasliar stroke Scheimann A. Alagille syndrome.

References

From eMedicine (cont.) Khan AN. Imaging in CNS toxoplasmosis Davis RG. Aicardi syndrome Sullivan BR. Lens particle glaucoma Dourmishev LA. Waardenburg syndrome Hanly J. Buerger disease (thromboangiitis obliterans) Rossman MG. Takayasu arteritis Saxena R. Alport syndrome Al-Uzri A. Lowe syndrome Pakzaban P. Chiari malformation Lang E. Vertebrobasilar atherothrombotic disease Seiff S. Capillary hemangioma Singhal H. Gardner syndrome Scott IU. Unilateral glaucoma Oakman JH. Posner-Schlossman syndrome Verdier D. Map-dot-fingerprint dystrophy Jacobs-Kosmin D. Polyarteritis nodosa Maakaron JE. Sickle cell anemia Farooqui SZ. Uveitis classification Janigian RH. Intermediate uveitis

References

From eMedicine (cont.) Foster CS. Dry eye syndrome Herzlich A. Ophthalmologic manifestations of Sjögren syndrome Farid-Moayer M. Churg-Strauss syndrome Tracy CL. Granulomatosis with polyangiitis Copeland R & Phillpotts BA. Ocular Manifestations of HIV Walton RC. Vogt-Koyanagi-Harada disease Schwartz RA. Dermatologic manifestations of Gardner syndrome Prieto VG. Muir-Torre syndrome Thacker N. Acquired exotropia Kutz JW. Acoustic neuroma Shah KN. Incontinentia pigmenti Hsieh DT. Neurofibromatosis type 1 Hsieh DT. Neurofibromatosis type 2 Janigian RH. Uveitis evaluation and treatment Brent LH. Ankylosing spondylitis and undifferentiated spondyloarthropathy Hammadi AA. Psoriatic arthritis Egan DJ. Endophthalmitis Abdel-Hamid HZ. Peroxisomal disorders Traverso CE. Choroidal detachment Singh D. Pseudophakic pupillary block

References

From the Focal Points series Falardeau J & Kardon R. Anisocoria. March 2013, 31/3 (3 of 3). Kiliç A & Colin J. Advances in the surgical treatment of keratoconus. March 2012, 30/2 (2 of 3). Lee KA. Pediatric diagnoses you don’t want to miss. September 2012, 30/9 (3 of 3). Stern GA. Chronic conjunctivitis Part 1. November 2012, 30/11 (2 of 3). Salim S. Medical treatment of glaucoma. December 2013, 31/10 (1 of 3). Morrison DG. Vertical strabismus. December 2013, 31/12 (3 of 3). Lowder CY & Lima BR. Pediatric uveitis. March 2014, 32/3. Wong AMF. A practical approach to nystagmus and saccadic oscillations. January 2014, 32/1. Patel VR. Transient monocular visual loss. July 2013, 31/7 (1 of 3). Katz BJ. The anomalous optic nerve. December 2011, 29/12 (3 of 3). El-Dairi MA & Bhatti MT. Headaches and facial pain for the ophthalmologist. September 2011,

29/7 (1 of 3). de Imus GC & Arpey CJ. Periorbital skin cancers: The dermatologist’s perspective. March 2006,

24/1 (1 of 3). Al-Sheikh M et al. Autofluorescence imaging of the retina. December 2017, 35/1 (2 of 3). Wall M. Idiopathic intracranial hypertension. September 2017, 35/7 (1 of 3).

References

From Review of Ophthalmology Bilyk JR. How to spot dangerous ptosis—the sequel. Accessed at

https://www.reviewofophthalmology.com/article/how-to-spot-dangerous-ptosisthe-sequel Ciulla TA. Targeting VEGF: The VEGF trap clinical trials. Dec. 2007, Part 1. Lin T & Mieler WF. Management of primary rhegmatogenous RD. 15(7), 57-62. Liu TT & Fintelmann R. Wills Eye resident case series. 16(2), 86, 84-85. Bethke W. Refractive surgery controversies to dread. 15(7), pp. 80-81. Zaslow CB & Patel A. Wills Eye resident case series. 15(8), p. 90. Ferrara DC, Freund KB, Yannuzzi LA. How to spot diseases that mimic wet AMD. 15(10), pp.

108-15. Bethke W. A sneak peek into the IOL pipeline. 11/1/07.

http://www.revophth.com/index.asp?page=1_13613.htm. Abelson MB. Acanthamoeba: A dangerous pathogen. 15(11), Part 1, 110 – 114. Wender JD, et al. How to recognize ocular syphilis. 15(11), Part 1, 124 – 130. Stephenson M. What's Next in Accommodative IOLs: New dual-optic, deformable and injectable

IOL technology is in various stages of development. 13(2), 2/15/2006. http://www.revophth.com/index.asp?page=1_874.htm.

Beiko GHH. Understanding corneal asphericity and IOLs., November 2008. http://www.revophth.com/content/d/features/i/1223/c/23024/

Tsai J & Karim MA. Current Concepts in Normal Tension Glaucoma. http://www.revophth.com/content/d/cover_focus/i/1304/c/25095/

Relhan N, Albini TA, and Flynn HW. Treating endogenous endophthalmitis. October 2014.

References

From Review of Ophthalmology cont Positive Results of Two Phase III Studies with VEGF Trap-Eye. April 2011.

http://www.revophth.com/content/d/review_news/c/25847/ Fleckenstein M et al. Fundus autofluorescence imaging in clinical use.

http://www.revophth.com/content/d/retina/c/22655/ Abelson MB & McLaughlin J. A close look at pseudoexfoliation. 21(8), 52-55. Mahajan S et al. Recognizing and treating ocular TB. Dec 2018, 51-55. Francis B. Glaucoma severity: Individualizing surgery. August 2019, 44-48.

References

From the JAMA Ophthalmology Clinical Challenge series Shen BA et al. A 12-month-old boy with bilateral facial swelling and proptosis. April 2018, 823-4. Moussa K et al. Blurry vision and eye pain after pterygium surgery. July 2018, 136(7), 827-8. Dahrouj M et al. Sudden-onset unilateral macular hemorrhage in a middle-aged man. 2018;

136(11), 1301-2. Francis AW et al. Rapid vision loss in a young woman. 2018; 135(12), 1404-5. Taubenslag KJ et al. A child with unilateral conjunctivitis and elevated inflammatory markers.

2018; 136(11), 1297-8. Machen L & MacIntosh P.Considerations in pediatric proptosis. 2018; 136(10), 1197-8. Ong SS & Postel EA.Sudden unilateral decrease in vision in a healthy middle-aged man. 2018;

136(11), 1299-1300. Birnbaum FA et al. Bilateral retinal detachments presenting with acute angle closure. August

2018, 136(8), 954-5. Desai S et al. Photophobia in an immunocompromised patient. August 2018, 136(8), 946-7. Crowell EL et al. Central scotoma after liver transplant. February 2019, 137(2), 214-5. Moussa K et al. Retinal exudates and hemorrhages in a survivor of breast cancer. February 2019,

137(2), 218-9. .Baim AD et al. Evaluation and management of unilateral congenital ptosis in a healthy child.

December 2017, 135(12), 1444-5. Patel AV et al. Under the guise of retinitis. October 2015, 133(10), 1205-6. Chodnicki KD et al. Pigmented macular lesion in a child. September 2019, 137(9), 1076-7.

References

From the JAMA Ophthalmology Clinical Challenge series (cont.) Shazly TA et al. A man with bilateral peripheral visual field loss. November 2017, 135(11), 1274-5. Wisely CE et al. A translucent cystic iris lesion. August 2019, 137(8), 951-2. Nahem K & Margolin EA. A special case of Horner syndrome. October 2016, 134(10), 1193-4. Ali FS & Rahimy E. Bilateral retinal whitening in a hospitalized patient. July 2017, 135(7), 809-10. Dhannawat SS et al. Nystagmus in an emaciated infant. November 2015, 133(11), 1349-50. Koo E & Campomanes AG. An adolescent with a swollen nerve. January 2015, 133(1), 97-8. Weng CY et al. Retinal findings leading to a change in diagnosis in a newborn child. February

2015, 133(2), 215-6. van Zyl et al. Vision loss and paresthesias in a young man. October 2015, 133(10), 1207-8 Stock M et al. Transient blurred vision in a neurologically decompensating patient. 132(7), 887-8. Calvo CM & Garg SJ. Bilateral visual disturbances in a young woman. 134(5), 593-4. Venincasa VD et al. Woman with sudden loss of vision. 131(4), 531-2. Andreoli MT & Lim JI. Cotton-wool spots and retinal hemorrhages. April 2014, 132(4), 503-4.

References

World Health Organization. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (PDF document). http://www.who.int/medicines/services/inn/RevisedFinalStemBook2006.pdf (plus addenda)

Various authors. New York Eye and Ear Infirmary: OKAP Board and Review (website). http://www.nyee.edu/okap-and-board-review---lecture-schedule.html

Hill WE. Intraocular lens power calculations (website). http://doctor-hill.com/physicians/physician_main.htm

Wilkinson M. Essential optics review for the boards (web version). http://www.medrounds.org/optics-review/index.html

Micromedex. Pegaptanib. http://www.micromedex.com/products/updates/drugdex_updates/de/pegaptanib.html

Nature reviews. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease . http://www.nature.com/nrd/journal/v5/n2/full/nrd1955.html

Shukla D, Namperumalsamy P, Goldbaum M, Cunningham Jr ET. Pegaptanib sodium for ocular vascular disease. Indian J Ophthalmol [serial online] 2007 [cited 2008 Jul 10];55:427-30. Available from: http://www.ijo.in/text.asp?2007/55/6/427/36476

Acute bacterial conjunctivitis. Handbook of Ocular Disease Management. http://cms.revoptom.com/handbook/oct02_sec2_4.htm

Marmor MF et al. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118(2), 415-422.

Montana CL & Apte RS. MEKanisms of a serous complication. JAMA Ophthalmology, 135(5), 413-14.

References

References Various authors. Basic and clinical science course of the American Academy of

Ophthalmology, 2002 – 2019 (all volumes). Kertes PJ & Conway MD. Clinical trials in ophthalmology: A summary and practice guide.

New York: Lippincott. Burde RM, Savino PJ & Trobe JD. Clinical decisions in neuro-ophthalmology (3rd edition).

London: Mosby. Rubin ML. Optics for clinicians (25th anniversary edition). Gainesville FL: Triad. Vander JF & Gault JA. Ophthalmology secrets. Philadelphia: Hanley & Belfus. Rhee DJ & Pyfer MF (Eds.) The Wills eye manual. New York: Lippincott. Quillen DA & Blodi BA. Clinical retina. AMA Press. Kanski JJ. Clinical ophthalmology: A systematic approach (3rd edition). Butterworth-

Heinemann. Lamkin JC. The Massachusetts Eye and Ear Infirmary review manual for ophthalmology.

New YorL Lippincott-Raven. Chern KC & Wright KW. Review questions in ophthalmology: A question and answer book.

New York: Lippincott. Skuta GL (Editor). PROvision: A self-assessment program from the American Academy of

Ophthalmology (Series 2). American Academy of Ophthalmology. Lane SS (Editor). PROvision: A self-assessment program from the American Academy of

Ophthalmology (Series 3). American Academy of Ophthalmology. Dhalla MS et al. Photodynamic therapy with verteporfin in age-related macular

degeneration. US Sensory Disorders 2006. http://www.touchbriefings.com/pdf/2106/Shah.pdf

Lim JI. The current state of therapy for age-related macular degeneration. Advanced Studies in Ophthalmology 4(5). Johns Hopkins Medicine CME.

Sadda SR. Monitoring therapeutic efficacy in the anti-VEGF era. Advanced Studies in Ophthalmology 4(5). Johns Hopkins Medicine CME.

Ho AC. Navigating AMD treatment options: Practical answers to complex questions. Advanced Studies in Ophthalmology 4(5). Johns Hopkins Medicine CME.

Mruthyunjaya P & Jaffe GJ. Summary. Advanced Studies in Ophthalmology 4(6). Johns Hopkins Medicine CME.

Shuler RK & Jaffe GJ. Summary. Advanced Studies in Ophthalmology 4(6). Johns Hopkins Medicine CME.

Bressler S. VEGF blockade for the management of ocular diseases other than AMD. Advanced Studies in Ophthalmology 7(1). Johns Hopkins Medicine CME.

Hasson M. Anti-VEGF agents have sparked swift, dramatic changes in AMD Treatment. Ocular Surgery News (Oct. 15, 2007).

Editors. Final trial results confirm consistency, superiority of anti-VEGF therapy. New Ophthalmologist (Sept. 2007).

Straka DG, Chang TC, Donahue SP. The case of the inscrutable infant. Eyenet 16(9), 65-67. Trattler WB. Optimizing outcomes with laser vision correction to enhance presbyopic IOL

results. In Expert strategies: Perioperative therapeutics in cataract and refractive surgery(Ocular Surgery News supplement, June 25, 2008).

References

Preliminary Results from a Phase IIIb Study Showed Patients with Wet AMD Treated with Lucentis Quarterly Experienced a 16-Letter Benefit over the Control Group at One Year. Genentech press release 6/2/06.http://www.gene.com/gene/news/press-releases/display.do?method=detail&id=9747

Fung AE, Lalwani GA et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthal 143(4);566-83. http://download.journals.elsevierhealth.com/pdfs/journals/0002-9394/PIIS0002939407000682.pdf

Dacheaux RF & Raviola E. Functional anatomy of the neural retina. In DM Albert and FA Jakobiec (Eds.), Principles and Practice of Ophthalmology (2nd Ed.) London: Saunders.

Roque MR. Hyperopia and presbyopia, conductive keratoplasty. eMedicine. http://www.emedicine.com/oph/topic736.htm

Groves N. Safety, outcomes of surface ablation versus lamellar surgery debated. Ophthalmology Times 33(11), p. 50.

Challenges in the diagnosis and treatment of ocular surface diseases. Ophthalmology Times CME supplement (release date 8/15/08).

Rajecki R. Consider masquerade syndromes when a differential diagnosis appears to indicate idiopathic uveitis. Ophthalmology Times 33(19), p. 58.

Scheimann A. Alagille syndrome. http://www.emedicine.com/ped/TOPIC60.HTM Anecortave acetate program terminated, says Alcon. Ophthalmology Times 33(14).

References

Charters L. OCT-guided re-treatment of neovascular AMD preserves drug benefits with fewer injections. Ophthalmology Times 33(14), p. 40.

Bhui RD & Karp CL. The case of the avid golfer. Eyenet 12(8), pp. 49-50. Lipner M. Eye on ocular melanoma. Eyeworld 13(10), pp. 20-21. Sub-Bowman’s keratomileusis. http://www.durrievision.com/index.cfm/procedures/sbk Macular degeneration gene link raises concerns over RNAi-based therapies.

http://www.myvisiontest.com/newsarchive.php?id=609. Patron ME & Duker JS. Girl referred for an unusual optic disc lesion. Ocular Surgery News

26(23), pp. 42, 40. Guttman C. Cataract 2008: A year in review. Ophthalmology Times 33(23), pp. 16-22. Beals JK. Gene variant protects against geographic atrophy in macular degeneration.

http://www.medscape.com/viewarticle/579936. NuLens presents a new concept for an accommodating IOL. Ophthalmology Times 9/18/04.

http://ophthalmologytimes.modernmedicine.com/ophthalmologytimes/article/articleDetail.jsp?id=123296.

Fine IH, Hoffman RS & Packer M. Perspectives in Lens & IOL surgery: Customizing IOL choice. Eyeworld Magazine August 2005. http://www.eyeworld.org/article.php?sid=2661.

Retinal macroaneurysm. Handbook of Ocular Disease Management.http://cms.revoptom.com/handbook/sect5p.htm

Abelson MB. Oral treatment options abound for dry eye. Ophthalmology Times 33(14), p. 12. Medcompare. Glaucoma drainage devices.

http://www.medcompare.com/quickpicks.asp?qpid=311.

References

Gene therapy may be an option for restoring vision in congenital blindness. Ocular Surgery News 26(21), pp. 20-21.

Experimental therapy may lead to macular degeneration. http://www.newswise.com/articles/view/543702/?sc=mwhn.

Beiko G. Status of accommodative intraocular lenses. Current Opinion in Ophthalmology18(1), pp. 74-79. http://www.co-ophthalmology.com/pt/re/coophth/pdfhandler.00055735-200702000-00016.pdf;jsessionid=JhWSZC2p55qD1672vknch18s62mvy1G95pT1YRlXxywY3rZrkdfN!1355756759!181195629!8091!-1.

Wang M (Ed.). Peer-Reviewed Literature: Accommodation and IOLs. Cataract and Refractive Surgery Today, Oct. 2006. http://www.crstoday.com/PDF%20Articles/1006/CRST1006_PR.php.

Fine IH et al. Update on Accommodative IOLs. Cataract and Refractive Surgery Today. http://www.crstodayarchive.com/03_archive/0103/crst0103_151.html.

Doane JF & Jackson RT. Accommodative intraocular lenses: considerations on use, function and design. Current Opinion in Ophthalmology 2007, 18:318–324. Jacksonhttp://www.v2020la.org/pub/PUBLICATIONS_BY_TOPICS/Cataract/Accommodative....pdf.

Nataloni R. IOLs are the future: The pipeline is flush with innovation. Ophthalmology Management, November 2005. http://www.ophthalmologymanagement.com/article.aspx?article=86491

The Synchrony dual-optic accommodating IOL. http://www.visiogen.com/aboutSynchrony.asp. Stodola E. The Hoffer H-5 formula incorporates gender and racial differences. EyeWorld

19(2), February 2014, 22-24.

References

Hayreh SS. Giant cell arteritis. http://webeye.ophth.uiowa.edu/dept/GCA/ Karmel M. On the near horizon: Better treatments for DME. EyeNet 13(1), 41 – 44. Russell SR & Rockwood EJ (Eds.). ProVision Series 5. AAO. Binder SP. Truly accommodating IOLs set the trend for presbyopia correction. Publication of

the European Society for Cataract and Refractive Surgery. http://www.escrs.org/PUBLICATIONS/EUROTIMES/07OCT/TRULYACCOMMODATINGIOLS.PDF

Fine IH, Hoffman RS, Packer M. The future of accommodating IOLs. Cataract and Refractive Surgery Today Europe, Sept 2008. http://www.crstodayeurope.com/Issues/0908/0908_14.pdf

Wilson R. Glaucoma around the world. In N. Devine (Ed.), Wills Eye Glaucoma Support Group. http://www.willsglaucoma.org/supportgroup/20050202.php

Aref AA et al. Dx and Tx of pigment dispersion syndrome and pigmentary glaucoma. EyeNet13(1), 37 – 39.

Hasson M. Better insight of cornea ushers in new generation of corneal refractive surgery. 2008 Year in Review: Perspectives in Ophthalmology, Dec. 2008, 12 – 16.

Screening examination of premature infants for retinopathy of prematurity. National Guideline Clearinghouse. http://www.guideline.gov/summary/summary.aspx?doc_id=8713

Doane JF. Accommodating intraocular lenses. In Davis EA et al (Eds.), Presbyopic lens surgery: A clinical guide to current technology. Thorofare NJ: Slack Inc. http://www.slackbooks.com/excerpts/67743/67743.asp.

Newman N. Update on optic neuritis. Presentation at the 59th annual symposium of the New Orleans Academy of Ophthalmology, February 2010.

References

Young M. Physicians hopeful for a dual-optic IOL. Eyeworld Magazinehttp://www.eyeworld.org/article.php?sid=2649

Karmel M. Glaucoma drops: Rx for success, or trouble? EyeNet 13(3), 39 – 43. Kellan R. An accommodative IOL with a new approach: The Kellan TetraFlex IOL. Cataract

and Refractive Surgery Today, Feb. 2004. http://www.crstoday.com/Old%20Archives/0204/crst0204%20art/crst0204_rs2_tetraflex.pdf

McGrath D. The surgical correction of presbyopia: Accommodation, pseudo-accommodation or multifocality? European Society of Cataract and Refractive Surgery Symposium Report2005. http://www.visiogen.com/libraryassets/Eurotimes%20ESCRS%20SymposiumReoprt%20March%202006.pdf

Foroozan R. New treatment for optic neuritis. 24th Annual Cullen Course, Houston TX. Stulting RD. Ectatic diseases of the cornea. 24th Annual Cullen Course, Houston TX. Carmody JN & Duker JS. Woman presents with scotoma after viral illness. Ocular Surgery

News 27(24), pp. 34 and 32. Newman N. Hereditary optic neuropathies. Presentation at the 59th annual symposium of the

New Orleans Academy of Ophthalmology, February 2010. Graham KB et al. Retinal manifestations of the acquired immunodeficiency syndrome:

Diagnosis and treatment. In DM Albert and FA Jakobiec (Eds.), Principles and Practice of Ophthalmology (2nd Ed.) London: Saunders.

Gressel MG. Lens-related glaucomas. http://www.oculist.net/downaton502/prof/ebook/duanes/pages/v3/v3c054a.html

References

Digre K. Inflammatory optic neuropathies. Presentation at the 59th annual symposium of the New Orleans Academy of Ophthalmology, February 2010.

Kafkala C. Psoriatic arthritis. www.uveitis.org/docs/dm/psoriatic_arthritis.pdf Newman N. Update on idiopathic intracranial hypertension (pseudotumor cerebri).

Presentation at the 59th annual symposium of the New Orleans Academy of Ophthalmology, February 2010.

Heier JS. Current challenges in the pharmacological treatment of central retinal vein occlusion. Viewpoint: A CME Newsletter Series (April 2010).

Newman N. Anterior ischemic optic neuropathy vs optic neuritis. Presentation at the 59th

annual symposium of the New Orleans Academy of Ophthalmology, February 2010. Friedman D. Risk factors for glaucoma and progression. Presentation at the 59th annual

symposium of the New Orleans Academy of Ophthalmology, February 2010. Clinical advances in the management of retinal vein occlusion. Peer View in Review, March

17, 2010. Swanic MJ & Reichel E. Man complains of shadowy vision in left eye. Ocular Surgery News

26(22), pp. 62, 60. Apple DJ & Rabb MF. Ocular pathology: Clinical applications and self-assessment. New York:

Mosby. Driebe WT & Bhatia SS. Superior limbic keratoconjunctivitis. In JH Krachmer, MJ Mannis and

EJ Holland, (Eds.), Cornea (2nd Edition). Philadelphia: Elsevier. London NJS et al. Drug-induced uveitis. Journal of Ophthalmic Inflammation and Infection

2013, 3:43. http://www.joii-journal.com/content/3/1/43

References

Shields MB. Iridocorneal endothelial syndrome. In DM Albert and FA Jakobiec(Eds.), Principles and Practice of Ophthalmology (2nd Ed.) London: Saunders.

Fuchs adenoma. The eye pathologist. http://eyepathologist.com/disease.asp?IDNUM=304980 Pathological myopia and posterior staphyloma. Handbook of ocular disease management.

http://cms.revoptom.com/handbook/oct02_sec5_3.htm Martin DF et al. A controlled trial of valganciclovir as induction therapy for cytomegalovirus

retinitis. NEJM 346(15), 1119-26. At http://www.pracaonze.ufrj.br/equipe/maurotrabs/66.pdf Schwartz GF & Donnenfeld ED. Is your patient trying to tell you something? Case studies in

the management of glaucoma. Pfizer monograph. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy.

http://one.aao.org/asset.axd?id=075b06c8-2b62-4c89-bd83-8dae181a9d8f Carpel EF. Iridocorneal endothelial syndrome. In JH Krachmer, MJ Mannis and EJ Holland,

(Eds.), Cornea (2nd Edition). Philadelphia: Elsevier. Macular Photocoagulation Study. eOphthalmology. http://www.eophtha.com/eophtha/st7.html Digre KB. IIH without papilledema exists. http://content.lib.utah.edu/utils/getfile/collection/ehsl-

nam/id/566/filename/567.pdf Rosenbaum JT. Nibbling away at the diagnosis of idiopathic uveitis. JAMA Ophthalmology,

2015; 133(2), 146-7. Wegener’s granulomatosis. The Johns Hopkins Vasculitis Center website.

http://www.hopkinsvasculitis.org/types-vasculitis/wegeners-granulomatosis/ Leng T. Management of Suspected Endogenous Endophthalmitis. Retina Today, Sept 2013.

http://retinatoday.com/2013/09/management-of-suspected-endogenous-endophthalmitis/

References

Samson CM. Ophthalmology Board Review Notes: Intermediate Uveitis, Posterior Uveitishttp://www.nyee.edu/pdf/okap-samson-uveitis.pdf

Smith, S. Microsporidia. http://www.stanford.edu/group/parasites/ParaSites2006/Microsporidiosis/microsporidia1.html

Ahmed I, Ai E, Chang E, and Luckie A. Ophthalmic Manifestations of HIV. HIV InSite. http://hivinsite.ucsf.edu/InSite?page=kb-04-01-12

Moorthy RS et al. Management of varicella zoster virus retinitis in AIDS. British Journal of Ophthalmology 1997;81:189-194. http://bjo.bmj.com/content/81/3/189.full

Drew WL & Lalezari JP. Cytomegalovirus and HIV. Ophthalmic Manifestations of HIV. HIV InSite. http://hivinsite.ucsf.edu/InSite?page=kb-05-03-03#S4.1X

Wilson PL et al. Illustrated handbook of ocular disease in HIV infection. New York: Parthenon. Owens DA. Normal variations of visual accommodation and binocular vergence: Some

implications for night vision. In Night vision: Current research and future directions, via books.google.com.

Moshirfar M. Spherical aberration of intraocular lenses. Journal of Ophthalmic and Vision Research 5(4), 215-16. http://www.jovr.ir/index.php/jovr/article/viewFile/246/266

Milder R & Rubin M. The fine art of prescribing glasses without making a spectacle of yourself. Gainseville FL: Triad.

Treating POAG: How Low Should IOP Go? Handbook of Ocular Disease Management. http://cms.revoptom.com/handbook/oct02_sec4_8.htm

http://www.reviewofophthalmology.com/content/d/retinal_insider/c/50867/

References

Seronegative spondyloarthropathies. Merck Manual online. http://www.merckmanuals.com/professional/sec04/ch034/ch034d.html

Klintworth GK. Siderosis bulbi. The eye pathologist.http://eyepathologist.com/disease.asp?IDNUM=311060

Nguyen MHT. Siderosis bulbi. Tufts Open Courseware. http://ocw.tufts.edu/Content/37/topics/487903

Zeppieri M.& Johnson CA. Frequency doubling technology. Imaging and Perimetry Society website. http://webeye.ophth.uiowa.edu/ips/perimetryhistory/FDP/index.htm

Shields JA & Shields CL. Intraocular tumors: An atlas and textbook. Accessed via http://books.google.com/books

Agarwal et al. Textbook of ophthalmology: Volume 1. Accessed via http://books.google.com/books

Vascular Endothelial Growth Factor(VEGF)Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration. ClinicalTrials.gov. http://clinicaltrials.gov/ct2/show/NCT00509795?term=VIEW&rank=4

Griggs PB. VEGF Trap for AMD: Phase 3 Clinical Trial. OphthalmologyWeb. http://www.ophthalmologyweb.com/FeaturedArticle.aspx?spid=23&aid=203

Seregard S. Conjunctival melanoma. Survey of Ophthalmology 42(4), pp. 321-350. Wheat LJ & Hage CA. Histoplasma capsulatum (Histoplasmosis).

http://www.antimicrobe.org/f06.asp Andreoli TE et al (Eds.). Cecil’s Essentials of Medicine, 4th edition. Philadelphia: Saunders.

References

Symblepharon. Digital Reference of Ophthalmology. http://dro.hs.columbia.edu/symblepharon.htm

Genetics Home Reference. NDP. http://ghr.nlm.nih.gov/gene/NDP Loughery J. RNA treatment appears safe, effective for AMD, DME patients. Ocular Surgery

News 26(9). Gragoudas et al. Pegaptanib for neovascular age-related macular degeneration. New

England Journal of Medicine 2004; 351:2805-16 Sims KB. NDP-related retinopathies. Bookshelf: US National Library of Medicine/NIH.

http://www.ncbi.nlm.nih.gov/books/NBK1331/ Toomes C & Downey L. Familial Exudative Vitreoretinopathy, Autosomal Dominant.

Bookshelf: US National Library of Medicine/NIH. http://www.ncbi.nlm.nih.gov/books/NBK1147/ Gever J. AMD drug study sparks concern. Medpage Today.

http://www.medpagetoday.com/Ophthalmology/GeneralOphthalmology/26204 The CATT Research Group. Ranibizumab and bevacizumab for neovascular age-related

macular degeneration. New England Journal of Medicine Online (10.1056/NEJMoa1102673) http://www.nejm.org/doi/full/10.1056/NEJMoa1102673?query=featured_home#t=article

Zierhut M, Deuter C & Murray PI. Classification of Uveitis – Current Guidelines. European Ophth Review 2007. Accessed online.

Miedziak A. 30 year old man with painless, slowly progressive, bilateral visual loss. Digital Journal of Ophthalmology. http://www.djo.harvard.edu/site.php?url=/physicians/gr/336

Weiss JS et al. IC3D classification of corneal dystrophies--Edition 2. Cornea 34(2), 117-59.

References

Cimberle M. Americans, Europeans divided over the use of intracameral cefuroxime. Ocular Surgery News 26(2).

Shields MB. Textbook of glaucoma (2nd edition). New York: Williams and Wilkins. Fujimoto FG et al. Principle of optical coherence tomography. In JS Schulman et al (Eds.)

Optical coherence tomography of ocular diseases. Thorofare, NJ: Slack. Lora A. Time domain versus spectral domain OCT in the diagnosis and treatment of

angioid streaks. Ophthalmology Web. http://www.ophthalmologyweb.com/FeaturedArticle.aspx?spid=23&aid=393

Forte R et al. Comparison of time domain stratus OCT and spectral domain SLO/OCT for assessment of macular thickness and volume. Eye 2009;23(11):2071-2078 (via Medscape at http://www.medscape.com/viewarticle/713298

Forooghian F et al. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. IOVS Oct 2008 vol. 49(10) 4290-4296. Accessed online at http://www.iovs.org/content/49/10/4290.full

Kellner U et al. Fundus Autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine. IOVS 47(8), 3531-38. http://www.iovs.org/content/47/8/3531.full

Vitamin A. NIH Office of Dietary Supplements. http://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/

References

Early Treatment Diabetic Retinopathy Study (ETDRS). http://clinicaltrials.gov/ct2/show/NCT00000151

Masket S. Accommodating IOLs: Emerging concepts and designs. Cataract and Refractive Surgery Today, July 2004. http://www.crstoday.com/PDF%20Articles/0704/crst0704_F1_Masket.pdf.

CATT, Hopkins data add fervor to ranibizumab vs. bevacizumab debate. Ocular Surgery News 29(15).

Charters L. Fusion protein yields visual benefit. Ophthalmology Times 36(15), p. 25. Charters L. Aflibercept approved for wet ARMD. Ophthalmology Times 36(23), p. 1. Prinzi R et al. Intermediate uveitis in children. EyeNet 16(1), 37-38. Heier JS, Boyer DS, Brown DM and Do DV. Innovative therapies for diabetic macular

edema: Preserving the fovea, restoring central vision: Challenging interactive clinical cases. Vindico CME supplement.

Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group. Abstract accessed via http://www.ncbi.nlm.nih.gov/pubmed/3658348?dopt=Abstract

Cox CA, and Goren JF. Woman has decreased vision, pain and photophobia in left eye: Grand rounds at the New England Eye Center. Ocular Surgery News 30(2), p. 42.

References

Interpretation of fluorescein angiography. http://www.mrcophth.com/ffainterpretation/ffaint.html

Zahran Y. How to read FA. http://www.scribd.com/doc/7743946/How-To-Read-fluorescein-angiography-ophthalmology#outer_page_3

Gupta. Fluorescein angiography refresher course. Review of Optometry Online. http://www.revoptom.com/content/d/news_review/c/18560/dnnprintmode/true/?skinsrc=[l]skins/ro2009/pageprint&containersrc=[l]containers/ro2009/simple

Interpretation of Stereo Ocular Angiography: Retinal Angiography Phases and Interpretation. http://telemedicine.orbis.org/bins/content_page.asp?cid=1-8989-8993-9002

Maximizing patient outcomes in AMD: A review of evolving, evidence-based therapeutic options for clinical practice. Supplement to Retina Today, September 2012.

Leach, B. FDA approves aflibercept for metastatic colorectal cancer. OncLive. http://www.onclive.com/web-exclusives/FDA-Approves-Aflibercept-for-Metastastic-Colorectal-Cancer

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) (VIEW1). http://clinicaltrials.gov/ct2/show/results/NCT00509795?term=VIEW+aflibercept&rank=1&sect=X25#all

Wittenberg S. 10 clinical pearls for treating uveitis. AAO Young Ophthalmologists Newsletter. http://www.aao.org/yo/newsletter/200808/article05.cfm

References

Young M. Updates on HSV. EyeWorld, January 2010. http://www.eyeworld.org/article-updates-on-hsv

NEWS: Two Year Results of Phase 3 Studies with EYLEA™ (aflibercept) Injection in wet AMD Show Sustained Improvement in Visual Acuity. http://www.clinicalophthalmology.com

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) (VIEW 2).

http://clinicaltrials.gov/ct2/show/results/NCT00637377?term=VIEW+aflibercept&rank=2&sect=X0125#all Two Year Results of Phase 3 Studies with EYLEA™ (aflibercept) Injection in wet AMD

Show Sustained Improvement in Visual Acuity. Online Regeneron press release. http://investor.regeneron.com/releasedetail.cfm?releaseid=629800

Mamalis N. Cataract surgery in pseudoexfoliation patients. Presentation at the 62nd annual symposium of the New Orleans Academy of Ophthalmology, January 2013.

Arbisser L. Tackling the brunescent cataract with grace and style. Presentation at the 62nd

annual symposium of the New Orleans Academy of Ophthalmology, January 2013. Waheed NK. HLA-B27-associated uveitis. www.uveitis.org 2007 report of the International Dry Eye Workshop. The Ocular Surface, April 2007, 5(2).

References

Lee A. NAION treatment; is there any treatment? Presentation at the 62nd annual symposium of the New Orleans Academy of Ophthalmology, January 2013.

Geffen N et al. Is the Ex-PRESS glaucoma shunt magnetic resonance imaging safe? Journal of Glaucoma 2010 Feb;19(2):116-8. Abstract accessed via PubMed: http://www.ncbi.nlm.nih.gov/pubmed/19661826

Important Safety Information for Surgical Glaucoma: EX-PRESS glaucoma filtration device. http://www.alconsurgical.com/ISI_Surgical-Glaucoma.aspx

Safety information: Glaucoma drainage implants. http://www.mrisafety.com/safety_article.asp?subject=190

Ginat DT et al. Imaging the postoperative orbit. In D. Ginat and P. Westesson (Eds.), Atlas of Postsurgical Neuroradiology: Imaging of the Brain, Spine, Head, and Neck. Berlin: Springer-Verlag. Accessed via: http://www.springer.com/cda/content/document/cda_downloaddocument/9783642158278-c1.pdf?SGWID=0-0-45-1352711-p174035559

Ophthotech's novel anti-PDGF combination agent Fovista demonstrated superior efficacy over Lucentis monotherapy in large controlled wet AMD trial. http://www.drugs.com/clinical_trials/ophthotech-s-novel-anti-pdgf-combination-agent-fovista-demonstrated-superior-efficacy-over-lucentis-13879.html

Krader CG. Look for clues to simplify anterior uveitis diagnosis. Modern Retina. Accessed online at https://www.modernretina.com/uveitis/look-clues-simplify-anterior-uveitis-diagnosis/page/0/3

References

Shaw J. Study of Bevacizumab for ROP Sparks Controversy. EyeNet. http://www.aao.org/publications/eyenet/201110/pediatrics.cfm

ROP clinical trials. FocusROP website. http://focusrop.com/rop-intrduction/21 Aggressive posterior ROP. FocusROP website. http://focusrop.com/rop-intrduction/44 Wong RK et al. Review and case discussion: Aggressive posterior Retinopathy of

Prematurity. Retinal Physician. http://www.retinalphysician.com/articleviewer.aspx?articleid=102109

John VJ et al. Avastin in ROP: The anti-VEGF drug has shown promise in the treatment of retinopathy of prematurity. Retinal Physician. http://www.retinalphysician.com/articleviewer.aspx?articleID=107527.

Ho AC and Lee HC. Macular hole. http://www.oculist.net/downaton502/prof/ebook/duanes/pages/v3/v3c021.html

Gaudric A and Tadayoni R. Macular hole. In SJ Ryan (Ed.), Retina, 1962-1978. Lee TC et al. Retinoblastoma. In SJ Ryan (Ed.), Retina, 2104-2149. Ekong T. Peripheral ulcerative keratitis.

http://www.uveitis.org/docs/dm/peripheral_ulcerative_keratitis-2.pdf Fraunfelder FT et al. The role of medications in causing dry eye. Journal of Ophthalmology.

http://www.hindawi.com/journals/joph/2012/285851/ Beiko GHH. The fundamentals of spherical aberration. Cataract and Refractive

Surgery Today, July 2012. http://crstodayeurope.com/2012/07/the-fundamentals-of-spherical-aberration

References

Zellweger spectrum disorder. Genetics home reference. http://ghr.nlm.nih.gov/condition/zellweger-spectrum-disorder

Stuart A. Toxic and nutritional optic neuropathy: First, undo harm. EyeNet 18(7), 36-42. JM Dijkstal. Scheie stripe in pigment dispersion syndrome.

http://webeye.ophth.uiowa.edu/eyeforum/atlas/pages/Scheie-stripe/index.htm Infantile neuronal ceroid lipofuscinosis. Genetics home reference.

http://ghr.nlm.nih.gov/condition/infantile-neuronal-ceroid-lipofuscinosis Belfer MH and Stevens RW. Sarcoidosis: A primary care review. American Family

Physician December 1998. https://www.aafp.org/afp/1998/1201/p2041.html Patel VR. How to work up Horner syndrome. AAO. Accessed online at

https://www.aao.org/1-minute-video/neurologic-basis-of-horner-s-syndrome Arterial system. AAO. Accessed online at

https://www.aao.org/bcscsnippetdetail.aspx?id=b1903368-6949-419a-9d37-3f712aa2e68d Mukherjee N et al. Optic nerve sheath fenestration--indications and techniques.

touchOphthalmology. Accessed online at https://www.touchophthalmology.com/articles/optic-nerve-sheath-fenestration-indications-and-techniques

Boyd K. What Is a Pinguecula and a Pterygium (Surfer's Eye)? https://www.aao.org/eye-health/diseases/pinguecula-pterygium

Colvard DM. Understanding the clinical behavior of ophthalmic viscoelastic devices. In DM Colvard (Ed.), Achieving Excellence in Cataract Surgery.

References

AA Aref et al. Dx and tx of pigment dispersion syndrome and pigmentary glaucoma. EyeNet January 2009. http://www.aao.org/publications/eyenet/200901/pearls.cfm

Ahned NR et al. Diagnosis and mamnagement of aniridia. EyeNet 18(11), 33-35. Spector RH. Visual Fields. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods:

The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 116. Available from: http://www.ncbi.nlm.nih.gov/books/NBK220/

National Cancer Institute. Ataxia Telangiectasia. http://www.cancer.gov/cancertopics/factsheet/Risk/ataxia

Hammes H-P et al. Pericytes and the pathogenesis of diabetic retinopathy. Medscapehttp://www.medscape.com/viewarticle/442151

Cleveland Clinic Laboratories technical brief. Syphilis serologic testing. Accessed online. Letko E. Measles. www.uveitis.org/docs/dm/measles.pdf Durrani K. Presumed ocular histoplasmosis syndrome.

www.uveitis.org/docs/.../presumed_ocular_histoplasmosis_syndrome-2.pdf Parnes A et al. The evaluation and management of optic disc melanocytoma. EyeNet, May

2011. Accessed online at https://www.aao.org/eyenet/article/evaluation-management-of-optic-disc-melanocytoma

Liu EM & Rothman RJ. More than meets the eye. EyeNet, February 2015. Accessed online at https://www.aao.org/eyenet/article/more-than-meets-eye

References

Asrani SG. MD roundtable: Diagnostic challenges of normal-tension glaucoma. EyeNet 22(6), 29-31.

Rogers DL. Pediatric idiopathic intracranial hypertension. AAO. Accessed online at https://www.aao.org/disease-review/neuro-ophthalmology-pediatric-idiopathic-intracran

Wilson-Pauwels et al. Cranial Nerves: Anatomy and Clinical Comments. Philadelphia: BC Decker.

Apolinario M et al. Know the differential disorders between the brain and eye. Ophthalmology Times 43(9), p. 17-20.

Pierre Robin sequence. Cincinnati Children’s Hospital Medical Center. https://www.cincinnatichildrens.org/health/p/pierre-robin-sequence

Physics curriculum guide: Refraction. http://www.sasked.gov.sk.ca/docs/physics/u3c12phy.html

Levine J. Light and color. http://www.colorado.edu/physics/phys1230/phys1230_fa01/index.html

Lima BR. Ophthalmic manifestations of HIV infection. Digital Journal of Ophthalmology. http://www.djo.harvard.edu/site.php?url=/physicians/oa/674

References